Fibrocell Appoints Michael F. Marino as Senior VP, General Counsel and Corporate Secretary

EXTON, Pa., June 1, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. FCSC, an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced the appointment of Michael F. Marino as Senior Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Marino is a seasoned legal advisor and executive with more than 14 years of experience advising publicly-traded and privately-held companies in a diverse range of industries—most notably life sciences, technology, manufacturing and banking, among others.   Prior to joining Fibrocell, Mr. Marino served as Senior Vice President, General Counsel and Secretary of NuPathe Inc., a NASDAQ-listed specialty pharmaceutical company that was acquired by Teva Pharmaceutical Industries Ltd. in 2014. Prior to NuPathe, Mr. Marino was an attorney at the law firms of Morgan, Lewis & Bockius LLP in Philadelphia and WilmerHale LLP in Boston, where his practice focused on mergers and acquisitions, joint ventures, financing transactions, corporate governance, securities law and general corporate law. Mr. Marino earned a B.S. in Accountancy from Villanova University and a J.D. from Boston College Law School. "Michael's distinguished leadership and strategic counsel experience in life sciences will See full press release